Endorsement by World Health Organization’s experts announced in Geneva
The World Health Organization has endorsed the use of the only approved vaccine against malaria on African children, in a major potential advance against a disease that kills hundreds of thousands of people annually.
The recommendation is for RTS,S, or Mosquirix, a vaccine developed by British drugmaker GlaxoSmithKline. It was jointly announced in Geneva by the WHO’s top advisory bodies for malaria and immunisation, the Malaria Policy Advisory Group and the Strategic Advisory Group of Experts on Immunisation.
